ReviewJournal of hematology & oncology2022

Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy.

Yun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.